Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 10:13:661.
doi: 10.12688/f1000research.150743.3. eCollection 2024.

Epidemiological characteristics and hospital outcomes of hospitalized Lassa fever cases during the 2022-2023 outbreak in Liberia

Emmanuel Dwalu  1 , Hannock Tweya  2 , Mher Beglaryan  3 , Chukwuma D Umeokonkwo  4 , Ralph W Jetoh  1 , Bode I Shobayo  1 , Fahn Tarweh  1 , Philip Owiti  5 , Pryanka Relan  6 , Shermarke Hassan  7 , George W Goteh  1 , Darius B Lehyen  1 , Louis Ako-Egbe  8 , Ibrahim Franklyn Kamara  9 , Godwin E Akpan  10 , Peter Adewuyi  10 , Patrick N Kpanyen  1 , Benjamin T Vonhm  1 , Julius S M Gilayeneh  1
Affiliations

Epidemiological characteristics and hospital outcomes of hospitalized Lassa fever cases during the 2022-2023 outbreak in Liberia

Emmanuel Dwalu et al. F1000Res. .

Abstract

Background: Lassa fever (LF) is an endemic and immediately notifiable disease in Liberia, and one laboratory confirmed case constitutes an outbreak. We described the epidemiological characteristics and hospital outcomes of LF cases hospitalized during the 2022-2023 outbreak in Liberia.

Methods: A retrospective cohort study was conducted using routine LF surveillance data from the 2022-2023 outbreak in Liberia. Descriptive statistics were used to summarize the data and log binomial regression to assess the association between epidemiological characteristics and mortality.

Results: A total of 439 suspected LF cases were reported. The median age was 22 (interquartile range (IQR): 10-33) years and 233 (53%) were females. The median number of days between symptom onset and admission was 4 (IQR 2-7). Of the 439 cases, 416 (95%) were tested for LF and 138 were confirmed with 33% positivity rate. The majority, 95 (69%), of confirmed cases were <30 years, 78 (57%) were females, and 81 (59%) were reported during the dry season (October - March). Contact with rodents, 95 (69%), was the commonest mode of exposure. Fever, 128 (93%), malaise, 121 (88%), headache, 114 (83%) and myalgia, 114 (83%) were the most common clinical presentations. There were 83 (19%) deaths among hospitalized suspected LF cases - 42 deaths (15%) among 278 individuals who tested negative and 41 among confirmed cases with 30% case fatality rate (CFR). Presenting CFR per age group, age 40-49 years accounted for 8/12 (67%) and those aged≥50 reported 5/8 (63%) of the deaths among the confirmed cases. There was no significant association between epidemiological characteristics and LF mortality.

Conclusions: The outbreak highlighted a high disease burden of LF with young adults disproportionately infected, and mortality, even among those who tested negative for the virus. This underscores the urgent need for preventive measures like vaccines and health education campaigns.

Keywords: Integrated Disease Surveillance and Response; Lassa fever; Liberia; SORT IT; case fatality rate; operational research; outbreak; positivity rate.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

Figures

Figure 1.
Figure 1.. Lassa fever diagnosis, treatment and hospital outcome, Liberia 2022-2023.
Figure 2.
Figure 2.. Geographical distribution of confirmed Lassa fever cases by reporting county, Liberia, 2022-2023.
Figure 3.
Figure 3.. Epi curve of confirmed Lassa fever cases and deaths by reporting week and year, Liberia, 2022-2023.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Ogbu O, Ajuluchukwu E, Uneke CJ: Lassa fever in West African sub-region: an overview. J. Vector Borne Dis. 2007;44:1. - PubMed
    1. Akpede GO, Asogun DA, Okogbenin SA, et al. : Caseload and case fatality of Lassa fever in Nigeria, 2001-2018: A specialist center’s experience and its implications. Front. Public Heal. Frontiers Media S.A. 2019;7:450510. - PMC - PubMed
    1. Merson L, Bourner J, Jalloh S, et al. : Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design. PLoS Negl. Trop. Dis. 2021;15:e0009788–e0009727. 10.1371/journal.pntd.0009788 - DOI - PMC - PubMed
    1. Lecompte E, Fichet-Calvet E, Daffis S, et al. : Mastomys natalensis and Lassa fever, West Africa. Emerg. Infect. Dis. 2006;12:1971–1974. 10.3201/eid1212.060812 - DOI - PMC - PubMed
    1. Yaro CA, Kogi E, Opara KN, et al. : Infection pattern, case fatality rate and spread of Lassa virus in Nigeria. BMC Infect. Dis. BMC. 2021 [citat 13 juliol 2023];21:1–9. Reference Source - PMC - PubMed

LinkOut - more resources